Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 18809609

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2008 Nov 10
First author
Penel N

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Penel N
      type
      Author
    2. name
      Bui BN
      type
      Author
    3. name
      Bay JO
      type
      Author
    4. name
      Cupissol D
      type
      Author
    5. name
      Ray-Coquard I
      type
      Author
    6. name
      Piperno-Neumann S
      type
      Author
    7. name
      Kerbrat P
      type
      Author
    8. name
      Fournier C
      type
      Author
    9. name
      Taieb S
      type
      Author
    10. name
      Jimenez M
      type
      Author
    11. name
      Isambert N
      type
      Author
    12. name
      Peyrade F
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Penel N
      type
      Author
    2. name
      Bui BN
      type
      Author
    3. name
      Bay JO
      type
      Author
    4. name
      Cupissol D
      type
      Author
    5. name
      Ray-Coquard I
      type
      Author
    6. name
      Piperno-Neumann S
      type
      Author
    7. name
      Kerbrat P
      type
      Author
    8. name
      Fournier C
      type
      Author
    9. name
      Taieb S
      type
      Author
    10. name
      Jimenez M
      type
      Author
    11. name
      Isambert N
      type
      Author
    12. name
      Peyrade F
      type
      Author
    bibliography ids
    1. nci-bib-1de2250c57da2c147c517eb0
    book metadata
    content sha256
    295188991c700297165f552ae79f39c281439fcc5b97ed48abf1183e16b3ea22
    document type
    citation
    dois
    1. 10.1200/JCO.2008.17.3146
    electronic publication date
    display
    2008 Sep 22
    precision
    day
    year
    2008
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:18809609
    immutable id
    pubmed:18809609@295188991c700297165f552ae79f39c281439fcc5b97ed48abf1183e16b3ea22
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    32
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    5269-74
    volume
    26
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      18809609
      provenance
      batch id
      6281e3e555c9a831cffc
      provider
      NCBI PubMed ESummary
      record sha256
      1478258ccf49754f481a83b9e9b3062a61a226f3677efd4d8f8a7b95bac42cd5
      response sha256
      0bb4ba3914464c472d4206a84abe8224c9e76dc003114204593648964c5bf66c
      retrieved at
      2026-09-09T23:46:21.772457+00:00
      publication date
      display
      2008 Nov 10
      precision
      day
      year
      2008
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/18809609/
      title
      Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.

      Preserved source evidence · Not medical advice